- Home
- TFIN vs CLDX Comparison
TFIN vs CLDX Comparison
Compare TFIN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- CLDX
- Stock Information
- Founded
- TFIN 1981
- CLDX N/A
- Country
- TFIN United States
- CLDX United States
- Employees
- TFIN N/A
- CLDX N/A
- Industry
- TFIN Major Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TFIN Finance
- CLDX Health Care
- Exchange
- TFIN Nasdaq
- CLDX Nasdaq
- Market Cap
- TFIN 1.4B
- CLDX 1.3B
- IPO Year
- TFIN N/A
- CLDX 2008
- Fundamental
- Price
- TFIN $54.43
- CLDX $20.50
- Analyst Decision
- TFIN Hold
- CLDX Buy
- Analyst Count
- TFIN 6
- CLDX 9
- Target Price
- TFIN $68.50
- CLDX $50.00
- AVG Volume (30 Days)
- TFIN 157.7K
- CLDX 1.2M
- Earning Date
- TFIN 07-16-2025
- CLDX 08-07-2025
- Dividend Yield
- TFIN N/A
- CLDX N/A
- EPS Growth
- TFIN N/A
- CLDX N/A
- EPS
- TFIN 0.37
- CLDX N/A
- Revenue
- TFIN $401,390,000.00
- CLDX $7,559,000.00
- Revenue This Year
- TFIN $12.09
- CLDX N/A
- Revenue Next Year
- TFIN $14.37
- CLDX N/A
- P/E Ratio
- TFIN $145.24
- CLDX N/A
- Revenue Growth
- TFIN 0.68
- CLDX 24.49
- 52 Week Low
- TFIN $42.90
- CLDX $14.40
- 52 Week High
- TFIN $110.58
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- TFIN 39.00
- CLDX 52.11
- Support Level
- TFIN $57.11
- CLDX $19.77
- Resistance Level
- TFIN $62.14
- CLDX $24.03
- Average True Range (ATR)
- TFIN 1.80
- CLDX 1.31
- MACD
- TFIN -0.62
- CLDX -0.00
- Stochastic Oscillator
- TFIN 4.34
- CLDX 26.15
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.